## 

## 

|CONTENTS|||||Page|
|---|---|---|---|---|---|
|Legal and administrative||information|||I|
|Trustees'<br>Report<br>incorporating|||a|Stri|2-18|
|Report||||||
|Independent<br>|Auditor's<br>|report|||19 - 21|
|Consolidated|statement|of  financial||acti|22|
|Charity and|Group balance sheets||||23|
|Consolidated|statement|of  cash flows|||24|
|Notes to the|financial|statements|||25 -  42|





|REGISTERED|REGISTERED|NAME|OF CHARITY||St Wilfrid's<br>Hospice<br>|St Wilfrid's<br>Hospice<br>|St Wilfrid's<br>Hospice<br>|(Eastbourne)|(Eastbourne)|(Eastbourne)|(Eastbourne)||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|CHARITY||NUMBER|||283686||||||||||||
|COMPANY||NUMBER|||01594410||||||||||||
|PRINCIPAL||OFFICE/REGISTERED||OFFICE|1 Broadwater<br>|Way|||||||||||
||||||Eastboume||||||||||||
||||||East Sussex||||||||||||
||||||BN22 9PZ||||||||||||
|PRESIDENT|||||HM The Queen||||||||||||
|PATRONS|||||The Duke of Devonshire||||||||||||
||||||Mr David<br>Dimbleby||||||||||||
||||||Dr Joan Hester||||||||||||
|TRUSTEES|||||Mr S O'Leaiy<br>|(Chair)|||||||||||
||||||Mr D Adams||||||||||||
||||||Dr  M  Barnes||||||||||||
||||||Mrs J Butler||||||||||||
||||||Ms L Chambers||(resigned||29 May|||2024)|||||
||||||Ms  B Hobson||||||||||||
||||||Mr D Holdsworth||||||||||||
||||||Ms  F Maclntyre||||||||||||
||||||Mr G Meyer||||||||||||
||||||Mrs M  Richardson||||||||||||
||||||Mr D Turner||||||||||||
|CHIEF<br>|EXECtJTIVE||||Mr C Twomey||||||||||||
|LEADERSHIP||TEAM|||Dr D Barclay<br>|(Medical||Director)|||||||||
||||||Ms  A  Dechamps<br>||(Patient||&|Family|||Support|Director)|||
||||||Mr D Mackenzie||(Finance||and||IT|Director)|||||
||||||Mrs P Russell|(Development||||Director)|||||||
||||||Mrs E Prodger|(Clinical<br>|||Services Director)<br>|||||(appointed<br>||2|
||||||October<br>2023)||||||||||||
||||||Mrs R Bacon (Associate<br>||||Director<br>|||for|Clinical||Services)||
||||||Mrs G Chandler||(Associate<br>|||Director|||for People||Services)||
||||||Dr L Free (Associate<br>|||Medical|||Director)||||||
||||||Mrs T Scmikker||(Associate<br>|||Director|||for Quality||||
||||||Improvement)||||||||||||
|AUDITORS|||||Haysmacintyre|LLP|||||||||||
||||||10 Queen Street||Place||||||||||
||||||London||||||||||||
||||||EC4R<br>1AG||||||||||||





## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 




## 

## 



## 

## 

## 



## 

## 

## 

||||2023/24|2022/23|Increase/decrease|Variance|
|---|---|---|---|---|---|---|
||||fk|Ek|Ek||
|Legacies|||2,230|3,848|(1,618)||
|Donations|and|Gifts|2,027|1,805|222||
|Lottery|||3 82|352|30|9|
|Trading|||1,397|1,260|137|11|





## 

|||2023-24|2022-23|
|---|---|---|---|
|||tk|tk|
||Patient Care|7,803  (73%)|7,051 (75%)|
||Fundraising|1,481  (14%)|1,237 (13%)|
|*|Trading|1,363 (13%)|1,154 (12%)|



## 

## 

## 

||2023/24|2022/23|
|---|---|---|
|Legacies|26%|40%|
|Gifts and Donations|24%|18%|
|Statutory Funding|27%|23%|
|Trading|16%|13%|
|Lottery|4%|4%|
|Investments/other|3%|2%|





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

|Risk identified|Risk identified||||||||Mitigation|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Uncertainty<br>||of income|||or  escalation||of costs||*|Rolling<br>|three-year|financial||plans|and|
|leading|to budget||deficit.|||||||scenario|planning|including||detailed||
|||||||||||financial|modelling|||||
||||||||||*|Utilise|legacy|income||projection||
|||||||||||planning|from external<br>consultancy|||||
||||||||||*|Achieve|effective<br>|strategic<br>|relationship|||
|||||||||||with NHS Integrated<br>Care|||Board|||
||||||||||*|Installation<br>of solar<br>panels||||to  create||
|||||||||||energy resilience||||||
||||||||||*|Regular<br>|cashflow<br>|reporting||||
||||||||||*|Reserves|policy in place with|||monitor||
|||||||||||by  Board|of Trustees<br>ensuring|||adequate||
|||||||||||reserves||||||
|Capacity|and|resilience<br>||issues including|||||*|Establish|successful|partnership||||
|establishment||of adequate|||staffing|levels||||working<br>|to realise|beiefits<br>|in|shared||
|||||||||||key roles||||||
||||||||||*|Approved|People|Strategy<br>|to|direct||
|||||||||||effective|workforce|planning||||
||||||||||*|Strong focus and  resources<br>|||for staff|||
|||||||||||wellbeing||||||
||||||||||*|Effective|use of volunteer<br>roles|||||
||||||||||*|Effective|staff feedback<br>mechanisms|||||
|||||||||||with action plans||||||
|Safeguarding||(used in||the broad||sense  of|||*|Safeguarding<br>Committee<br>in|||place with|||
|keeping<br>|safe|from<br>|harm).|||||||Trustee<br>as Chair||||||
||||||||||*|Mandatory|training|in place|with|||
|||||||||||monitor<br>|of compliance|||||
||||||||||*|Safeguarding<br>risk||register<br>to monitor||||
|||||||||||and  scnitinise<br>risk||||||
||||||||||*|Speak up policy<br>and  procedure||||||
|||||||||||including|whistleblowing<br>and|||||
|||||||||||availability|of Freedom<br>to Speak Up|||||
|||||||||||Guardians||||||
||||||||||*|Safeguarding<br>Lead||in role||||
|Short/long-term||disniption|||to business||caused by||*|Major<br>incident<br>and||business|continuity|||
|major event or||systems failure||||||||policy<br>in|place with|annual|exercise<br>||to|
|||||||||||test  procedures||||||
|||||||||It||||||||





## 

||||||*|Fire risk assessment<br>reviewed|bi-|
|---|---|---|---|---|---|---|---|
|||||||annually||
||||||*|Infection<br>prevention<br>and control||
|||||||policies<br>and  procedures<br>in place with||
|||||||audits||
||||||*|Strengthened<br>IT  infrastnichires|with|
|||||||third pariy support<br>included||
|Fraud,|theft|andcyber crime.|||*|Payroll<br>database implemented|with|
|||||||improved<br>safety||
||||||*|Building<br>security<br>upgraded<br>including||
|||||||additional<br>CCTV||
||||||*|Cash handling<br>policies<br>and  procedures||
|||||||in place||
||||||*|Incident<br>reporting<br>encouraged|to|
|||||||identify<br>trends and  learning||
|||||||opportunities||
||||||*|Improved<br>firewall<br>struchires||
||||||*|Implementation<br>of financial||
|||||||management<br>database with|improved|
|||||||security||
|Information||governance|-  data breach|or|*|Data protection<br>and security|policies|
|other<br>|data|error.||||and  procedures<br>in place with|oversight|
|||||||by Data Protection<br>and security||
|||||||steering<br>group reporting<br>to|Audit|
|||||||Committee||
||||||ii|Key information<br>governance|roles in|
|||||||place: IG Lead, Senior Information||
|||||||Risk Officer,<br>Caldicott<br>Guardian||
||||||ii|Compliance<br>with NHS Data|Security|
|||||||and  Protection<br>toolkit||
||||||*|Mandatory<br>training<br>with compliance||
|||||||monitor<br>in place||



## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 



||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||Funds|Funds|2024|2023|
|||Notes|E.|t|||
|INCOME<br>FROM:|||||||
|Donations<br>and Legacies||2|3,976,208|280,895|4,257,103|5,654,153|
|Charitable<br>Activities|||||||
|Stahitory<br>Funding||2|1,697,672||1,697,672|1,692,638|
|Non-Statutory<br>Funding||2|592,424||592,424|536,744|
|Other<br>trading<br>activities|||||||
|Income<br>from Trading||3|1,396,838||1,396,838|1,260,238|
|Income<br>from Lottery|||381,952||381,952|352,349|
|Investments||4|204,006||2 04,006|138,165|
|Other||5|19,498||19,498|56,334|
|Total<br>Income|||8,268,598|280,895|8,549,493|9,690,621|
|EXPENDITURE<br>ON:|||||||
|Raising<br>Funds|||||||
|Fundraising<br>Costs||6|1,481,183||1,481,183|1,237,299|
|Trading<br>Costs of Goods|Sold||||||
|and  Other Costs||3|1,362,976||1,362,976|1,154,486|
|Charitable<br>activities|||||||
|In  Patient||6|3,641,590|68,195|3,709,785|3,419,869|
|Therapies||6|511,258|16,642|527,900|507,946|
|Community<br>Nursing||6|2,966,614|49,711|3,016,325|2,620,651|
|Patient &  Family<br>Support||6|432,556|116,500|549,056|502,525|
|Total<br>Expenditure|||10,396,177|251,048|10,647,225|9,442,776|
|Net income/(expenditure)|||||||
|before<br>net gains/(losses)|on||(2,127,579)|29,847|(2,097,732)|247,845|
|investments|||||||
|Net gains/(losses)<br>on||13|165,309||165,309|(145,827)|
|investments|||||||
|Net income/(expenditure)|||(1,962,270)|29,847|(1,932,423)|102,018|
|Gross transfers<br>between|funds|19|14,762|(14,762)|||
|Net movement<br>in  funds|||(1,947,508)|15,085|(1,932,423)|102,018|
|Fund balances at1 April|2023||19,830,095|49,253|19,879,348|19,777,330|
|Fund balances<br>at 31|March|20,21|17,882,587|64,338|17,946,925|19,879,348|
|2024|||||||





## 

## 

||||||Hospice||Group||
|---|---|---|---|---|---|---|---|---|
|||||2024|2023|2024||2023|
||||Notes|:E|t||||
|FIXED<br>ASSETS|||||||||
|Tangible assets|||12|9,466,070|9,506,686|9 466 070||9,506  686|
|Investments|||13|4,713,749|4,493,457|4 713 648||4 493,356|
|||||14 ,179,819|14,000,143|14 179 718||14000042|
|CURRENT|ASSETS||||||||
|Stocks||||5,965|<br>5,463|9,745||10,964|
|Debtors|||14|2,178,580|2,986,786|2,143,665||2,932,554|
|Cash  at bank and in hand||||2,185,941|<br>4,434,083|2,244,199||4,498,075|
|||||4,370,486|7,426,332|4,397,609||7,441,593|
|CREDITORS:|amounts||||||||
|falling due|within|one year|15|(606,945)|(1,549,641)|(630,402)||(1,562,287)|
|NET CURRENT<br>||ASSETS||3,763,541|5,876,691|3,767,207||5,879,306|
|TOTAL<br>ASSETS<br>||LESS|||||||
|CURRENT|LIABILITIES|||17,943,360|19,876,834|17,946,925||19,879,348|
|NET ASSETS||||17,943,360|19,876,834|17,946,925||19,879,348|
|FUNDS:|||||||||
|Restricted<br>funds|||18|64,338|<br>49,253|64,338||49,253|
|Unrestricted|funds:||||||||
|Designated<br>|funds||19|12,310,482|13,911,275|13,443,963||13,911,275|
|Operating<br>reserve|||19|5,568,540|5,916,306|4,438,624||5,918,820|
|||||17,943,360|19,876,834|17,946,925||19,879,348|





## 

|||||||||2024|2023|
|---|---|---|---|---|---|---|---|---|---|
||||||||Note|||
|Cash flows from operating||activities:||||||||
|Net cash  provided<br>by operating<br>acaviaes|||||||21|(2,051,916)|797,487|
|Cash flows from investing||activities:||||||||
|Dividends,<br>interest and rents  from investments||||||||204,006|138,165|
|Proceeds from the sale of|plant and equipment|||||||192||
|Purchase of property, plant||and equipment||||||(351,175)|(138,437)|
|Purchase of  investments||||||||(596,900)|(1,387,600)|
|Disposal of  investments||||||||532,555|1,075,458|
|Movement<br>in investment<br>|cash|||||||9,362|7,717|
|Net  cash  (used in)  investing||activities||||||(201,960)|(304,697)|
|Change in  cash  and  cash||equivalents<br>|in|the  reporting|period|||(2,253,876)|(492,790)|
|Cash and cash equivalents||at the beginning||of  the reporting||period||4,498,075|4,005,285|
|Cash and  cash  equivalents||at the  end|of|the  reporting||period||2,244,199|4,498,075|





## 

## 

||ACCOUNTING<br>POLICIES||||||
|---|---|---|---|---|---|---|
||The principal<br>accounting<br>policies<br>adopted,<br>judgements<br>and  key  sources of|judgement,<br>estimation,||and  uncertainty|||
||in the  preparation<br>of the  financial<br>statements<br>are as follows:||||||
||Statement<br>of compliance||||||
||The financial<br>statements<br>have been prepared<br>in accordance<br>with Accounting|and  Reporting<br>by|Charities:||||
||Statement<br>of Recommended<br>Practice<br>applicable<br>to charities<br>preparing<br>their|accounts<br>in accordance||with|the||
||Financial<br>Reporting<br>Standard<br>applicable<br>in the  {JK and Republic<br>of Ireland|(FRS  102) - (Chai'ities||SORP||Second|
||Edition,<br>effective<br>1 January 2019), the Financial<br>Reporting<br>Standard<br>applicable<br>in  the  UK and||Republic<br>||of||
||Ireland<br>(FRS 102) and  the  Companies<br>Act 2006.||||||
||St Wilfrid's<br>Hospice<br>(Eastbourne)<br>meets the definition<br>of a public benefit<br>entity under FRS  102.||ASsets and||||
||liabilities<br>are initially<br>recognised<br>at historical<br>cost  or  transaction<br>value unless|otherwise<br>stated in|the|relevant|||
||accounting<br>policy<br>note(s).||||||
|1.2|General<br>information||||||
||The charity<br>is a private<br>company<br>limited<br>by  guarantee,<br>incorporated<br>in England<br>and Waies (company<br>number:||||||
||01594410)<br>and a charity<br>in England<br>and  Wales (charity<br>number:<br>283686).<br>The charity's<br>registered<br>|||office|is 1||
||Broadwater<br>Way, Eastbourne,<br>East  Sussex, BN22 9PZ.||||||
|1.3|Preparation<br>of accounts<br>on  a going concern<br>basis||||||
||At  the time of approving<br>the  financial<br>statements,<br>Trustees have a reasonable|expectation<br>that  the||charity<br>||has|
||adequate resources<br>to continue<br>in operational<br>existence<br>for the  foreseeable<br>|future. In  addition,<br>|through||||
||appropriate<br>consideration<br>of risks as part of its normal risk management<br>processes<br>and  mitigating|||actions||both|
||already taken and  available<br>to be taken, the  Trustees<br>consider<br>there are no material<br>uncertainties||about the||||
||Charity's<br>ability<br>to continue<br>as a going concern. <br>The  review<br>of the Charity's|financial<br>position,|reserves||levels||
||and  future plans gives Trustees<br>confidence<br>the Charity<br>remains<br>a going concern<br>for the  foreseeable|||future.|||
|1.4|Group<br>financial<br>statements||||||
||The financial<br>statements<br>consolidate<br>the  results of the  charity and  its wholly|owned subsidiary<br>|St|Wilfrid's|||
||Hospice<br>Eastbourne<br>Trading<br>Company<br>Limited<br>(registered<br>number:<br>02198239).<br>The results of||the|wholly||owned|
||subsidiaiy,<br>St Wilfrid's<br>Hospice<br>(Eastbourne)<br>Projects<br>Limited,<br>has not  been consolidated<br>into||these financial||||
||statements<br>as its results are immaterial<br>to the  charity<br>and group. A  separate|Statement<br>of Financial||Activities||and|
||Income<br>and  Expenditure<br>Account<br>for the  charity<br>has not  been presented<br>because the  charity<br>has taken advantage||||||
||of the  exemption<br>afforded<br>by  section 408  of the  Companies<br>Act 2006. The|registered<br>office for|these  subsidiaries||||
||is the  same as the parent.||||||





## 



## 

|1.9|Financial<br>instruments||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||The charity<br>only has financial<br>assets  and  financial<br>liabilities<br>of a kind|||that  qualify<br>|as basic|financial||instruments.|||||
||Basic financial<br>instruments<br>are initially|recognised<br>at transaction<br>value||and  subsequently<br>measured||||at|their||||
||settlement<br>value with the  exception<br>of|bank loans which are subsequently<br>measured|||at amortised<br>||cost||using|||the|
||effective<br>interest<br>method.||||||||||||
|1.10|Investments||||||||||||
||Investments<br>are a fomi of basic financial|instniments<br>and are initially<br>shown in the financial<br>||||statements||at||market|||
||value. Movements<br>in the  market values|of investments<br>are shown as unrealised<br>gains|||and  losses in the|||Statement||||of|
||Financial<br>Activities.||||||||||||
||Profits and  losses  on the realisation<br>of investments<br>are shown as realised|||gains and  losses in the  Statement||||||of|||
||Financial<br>Activities.<br>Realised<br>gains and|losses on investments<br>are calculated<br>between|||sales  proceeds||and||their||||
||opening<br>cariying<br>values or their purchase value if acquired subsequent<br>||to the first day  of the|||financial||year.|||||
||Unrealised<br>gains and  losses are calculated<br>as the  difference<br>between<br>the|||fair value at|the  year|end  and||their||carrying|||
||value. Realised<br>and  unrealised<br>investment|gains and  losses  are combined||in the Statement<br>of||Financial||Activities.|||||
|1.11|Stock||||||||||||
||Stock consists of purchased<br>goods for resale. Stocks are valued at the||lower of cost||and  net|realisable|||value.||||
||Items donated<br>for resale or  distribution<br>|are  not  included<br>in the  financial||statements<br>|untilthey|are sold or|||||||
||distributed.||||||||||||
|1.12|Creditors<br>and provisions||||||||||||
||Creditors<br>and  provisions<br>are recognised|where the charity has a present||obligation<br>|resulting|from a past||||event||that|
||will probably<br>result in  the  transfer<br>of funds to a third party and  the  amount<br>due  to settle the|||||obligation|||can  be||||
||measured<br>or estimated<br>reliably.<br>Creditors<br>and  provisions<br>are normally<br>|||recognised<br>at their settlement||||amount||||after|
||allowing<br>for any  trade discounts<br>due.||||||||||||
|1.13|Debtors||||||||||||
||Trade and  other debtors are recognised<br>|at the  settlement<br>amount<br>due  after any  trade|||discount|offered.|||||||
||Prepayments<br>are valued at the  amount<br>|prepaid<br>net of any  trade discounts||due.|||||||||
|1.14|Cash at bank<br>and in  hand||||||||||||
||Cash at bank and  cash  in hand includes<br>|cash  and  short temi highly<br>liquid<br>investments|||with|a short|maturity<br>||||of||
||three months<br>or less from the  date  of acquisition<br>or opening<br>of the  deposit<br>or similar||||account.||||||||
|1.15|Pensions||||||||||||
||The charity<br>operates a defined<br>contribution<br>pension scheme. Contributions|||are charged in<br>the accounts|||||as they||||
||become payable<br>in accordance<br>with the|rules ofthe scheme.|||||||||||
|1.16|Donated<br>goods||||||||||||
||The Tnistees<br>consider<br>the  valuation<br>of donated<br>goods for resale at the||point of receipt is impractical,|||||due||to|the||
||high volume<br>of low value items and  the|administrative<br>costs  involved<br>|in valuation.<br>||Goods donated<br>||for||resale|||are|
||therefore<br>recognised<br>in the  accounts<br>at the  point of sale.||||||||||||
|1.17|Fund<br>accounting||||||||||||
||General funds are unrestricted<br>funds which<br>are available<br>for use at the||discretion<br>of||the  trustees <br>in||furtherance|||||of|
||the  general objectives<br>of the  charity<br>and|which have not  been  designated||for  other purposes.|||||||||
||Designated<br>funds comprise<br>unrestricted<br>|funds that have been set aside|by  the  trustees for particular<br>||||purposes.|||||The|
||aim and  use  of each  designated<br>fund is set out  in the  notes to the  financial|||statements.|||||||||
||Restricted<br>funds comprise<br>funds received|for a specific<br>expenditure<br>as|specified<br>by||the  donor. The||aim||and  use of||||
||each  restricted<br>fund is set out  in the notes to the  financial<br>statements.||||||||||||





## 

## 

## 

|2.|DONATIONS,<br>LEGACIES|AND|Unrestricted|Restricted||
|---|---|---|---|---|---|
||ST ATUTORY<br>FUNDING||Funds|Funds|2024|
||Donations<br>and  Gifts||1 ,745,795|280,895|2,026,690|
||Legacies<br>Receivable||2,230,413||2,230,413|
||||3,976,208|280,895|4,257,103|
||Grants Receivable<br>for Core|Activities||||
||Statutoiy<br>Funding||1,697,672||1,697,672|
||Non-Statutory<br>Funding||592,424||592,424|
||||6,266,304|280,895|6,547,199|
||DONATIONS,<br>LEGACIES|AND|Unrestricted|Restricted||
||ST ATUTORY<br>FUNDING||Funds|Funds|2023|
||Prior<br>Year<br>-  2023|||||
||Donations<br>and  Gifts||1,550,470|255,083|1,805,553|
||Legacies<br>Receivable||3,848,600||3,848,600|
||||5,399,070|255,083|5,654,153|
||Grants Receivable<br>for Core|Activities||||
||Statutory<br>Funding||1,692,638||1,692,638|
||Non-Statutory<br>Funding||536,744||536,744|
||||7,628,452|255,083|7,883,535|





|ACTIVITIES<br>|FOR GENERATING|FUNDS||2024|||2023||
|---|---|---|---|---|---|---|---|---|
|Trading<br>income|and costs||||||||
|Trading<br>income|||||||||
|Donated<br>goods|income||1,132,944|||1,048,977|||
|Bought<br>in goods|income||34,753|||43,682|||
|Street cafi: income|||229,141|||167,579|||
|Other operating<br>|income||||||||
||||||1,396,838|||1,260,238|
|Trading<br>expenses|||||||||
|Cost of sales|||48,284|||35,877|||
|Street caf6 costs|||207,442|||155,462|||
|Staff expenses|||517,954|||475,443|||
|Propeity<br>expenses|||472,613|||351,518|||
|Administration<br>|expenses||99,004|||135,815|||
|Dilapidations/Depreciation|||17,679|||371|||
||||||1,362,976|||1,154,486|
|Less interest received|||(503)|||(170)|||
||||||1,362,473|||1,154,316|
|Total<br>(deficit)/surplus|||||34,365|||105,922|
|Number<br>of shops|||||12|||11|





## 

||INVESTMENT|INCOME|INCOME|INCOME|-|tJNRESTRICTED|||2024|2023|
|---|---|---|---|---|---|---|---|---|---|---|
||Rental income|from|investment|||properties|||30,923|25,328|
||Income from listed||investments||||||83 482|80 669|
||Interest receivable||||||||89 601|32,168|
||||||||||204 006|138,165|
||OTHER<br>INCOME||-|UNRESTRICTED|||||2024|2023|
||Other Income||||||||19 498|56,334|
||||||||||19 498|56,334|
|6.|TOTAL<br>EXPENDITURE||||||Other|Support|||
|||||||Staff|Direct|Costs|Total||
|||||||Costs|Costs|Allocation|2024||
||||||||||;E||
||Charitable<br>expenditure||||||||||
||Primary<br>costs||||||||||
||In Patient|||||2,196,242|224,417|1,289,126|3,709,785||
||Therapies|||||331,776|20,334|175,790|527,900||
||Community<br>|Nursing||||1,734,602|31,661|1,250,062|3,016,325||
||Patient & Family||Support|||346,326|7,408|195,322|549,056||
|||||||4,608,946|283,820|2,910,300|7,803,066||
||Costs of  generating|||funds|||||||
||Non-charitable|Trading||||517,954|845,022||1,362,976||
||Fundraising|||||569,815|481,660|429  708|1,481,183||
|||||||5,696,715|1,610,502|3,340,008|10,647,225||
||SUPPORT<br>COSTS||||||||2024||
||||||||||Total||
||Support staff||||||||1.678.955||
||Office||||||||389 437||
||Premises and|utilities|||||||1.244 424||
||Governance||||||||27 192||
||||||||||3,340,008||
||GOVERNANCE||COSTS||||||||
||Legal and professional||||||||8,892||
||Auditors'<br>remuneration||||||||18,300||
||||||||||27,192||





## 

## 

|Prior Year|-|2023||||||
|---|---|---|---|---|---|---|---|
|||||Staff|Other|Support|Total|
||||||Direct|Costs||
|||||Costs|Costs|Allocation|2023|
|Charitable|expenditure|||||||
|Primary<br>costs||||||||
|In Patient||||2,031,113|156,330|1,232,426|3,419,869|
|Therapies<br>Community||Nursing||311,868<br>1,534,596|22,497<br>44,568|173,581<br>1,041,487|507,946<br>2,620,651|
|Patient &|Family Support|||303,296|8,290|190,939|502,525|
|||||4,180,873|231,685|2,638,433|7,050,991|
|Costs of  generating<br>|||funds|||||
|Non-charitable||trading||475,443|679,043||1,154,486|
|Fundraising||||497,734|409,761|329,804|1,237,299|
|||||5,154,050|1,320,489|2,968,237|9,442,776|
|SUPPORT<br>|COSTS||||||2023|
||||||||Total|
|Support staff<br>Office|||||||1 ,496,008<br>208,669|
|Premises and utilities|||||||1,237,405|
|Governance|||||||26,155|
||||||||2,968,237|
|GOVERNANCE||COSTS||||||
|Legal and professional|||||||6,940|
|Auditors'<br>remuneration|||||||19,215|
||||||||26,155|





## 

|7.|NET INCOME/(EXPENDITURE)|2024|2023|
|---|---|---|---|
||Net income<br>is stated after:|||
||Auditors'<br>remuneration|||
||-<br>Audit<br>services|19,500|17,015|
||-<br>Non-audit<br>services|1,600|2,200|
||Depreciation|391,791|429,359|



## 

|||||||||||||Hospice|and Group|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|EMPLOYEES||||||||||||2024|2023|
|||||||||||||Number|Number|
|The average||monthly||number||of|employees|during||the|year was:|||
|In  Patient||||||||||||66||
|Therapies||||||||||||9||
|Community||Nursing||||||||||64||
|Patient &|Family<br>||Support|||||||||10||
|Support<br>staff||||||||||||55||
|Fundraising||||||||||||22||
|Retail||||||||||||25||
|||||||||||||251||
|The full-time||equivalent<br>|||number||of employees||at|March|was:|||
|Inpatient<br>Therapies||||||||||||42<br>7|38<br>8|
|Community<br>Patient &|Nursing<br>Family<br>Support|||||||||||39<br>7|38<br>7|
|Support<br>staff<br>Fundraising||||||||||||43<br>17|36<br>15|
|Retail||||||||||||20|17|
|||||||||||||175|159|
|Etnployment||costs||||||||||||
|Wages and||salaries||||||||||6,323,867|5,685,319|
|National<br>|insurance|||||||||||543,258|496,698|
|Pension<br>|costs|||||||||||508,545|452,264|
|Redundancy||costs|||||||||||15,777|
|||||||||||||7,375,670|6,650,058|





## 

## 

## 

|The<br>nu<br>f60,000<br>|mber <br>of<br>employees <br>whose<br>annual<br>remun<br>or more  were:|eration <br>was||
|---|---|---|---|
|||2024|2023|
|||Number|Number|
|E60,000|- E70,000||1|
|E70,000|- f80,000||2|
|f80,000<br>|- f90,000|||
|E90,000|- EIO0,000||l|
|EIO0,000|- fll0,000|||
|El  10,000|- fl20,000|||



## 

## 

|rs<br>ospce<br>(Eastbourne)<br>under a<br>is shown below.|ift Aid Declaration.<br>A summary<br>of its<br>tr|ading results|
|---|---|---|
||2024|2023|
||t|t|
|Turnover<br>Other operating income|263,894|211,261|
|Expenditure|(234,939)|(177,917)|
|Operating(loss)/profit<br>Interestreceivable|28,955|33,344|
||503|170|
|(Loss)/profit<br>for the  year|29,458|33,514|
||2024|2023|
|Tangible fixed ASSETS|||
|Current assets<br>Current liabilities|86,259<br>(54,185)|92,742<br>(57,890)|
|Net  (liabilities)/assets|32,074|34,852|
|Capital<br>and reserves|32,074|34,852|





## 

## 

|||||Fixtures|||
|---|---|---|---|---|---|---|
|Hospice|Land and|Computer|Plant and|And|Motor||
||Buildings|Equipment|equipment|Fittings|Vehicles|Total|
|||||t|t|t|
|Cost|||||||
|At  1 April 2023|11,061,021|522,209|140,435|601,501|86,904|12,412,070|
|Additions||33,165|292,609|25,401||351,175|
|Disposals|||||(3,200)|(3,200)|
|At  31 March 2024|11,061,021|555,374|433,044|626,902|83,704|12,760,045|
|Depreciation|||||||
|At  l April 2023|1 ,922,858|424,674|107,987|385,795|64,070|2,905,384|
|Charge for the year|2 02,094|75,647|35,873|70,525|7,652|391,791|
|On disposals|||||(3,200)|(3,200)|
|At  31 March 2024|2,124,952|500,321|143,860|456,320|68,522|3,293,975|
|Net Book Value|||||||
|At  31 March 2024|8,936,069|55,053|289,184|170,582|15,182|9,466,070|
|At  31 March 2023|9,138,163|97,535|32,448|215,706|22,834|9,506,686|
|Group|||||||
|Cost|||||||
|At I April 2023|11,061,021|523,859|140,435|601,501|86,904|12,413,720|
|Additions||33,165|292,609|25,401||351,175|
|Disposals|||||(3,200)|(3,200)|
|At  31 March 2024|11,061,021|557,024|433,044|626,902|83,704|12,761,695|
|Depreciation|||||||
|At 1 April 2023|1,922,858|426,324|107,987|385,795|64,070|2,907,034|
|Charge for  the year|202,094|75,647|35,873|70,525|7,652|391,791|
|On disposals|||||(3,200)|(3,200)|
|At  31 March 2024|2,124,952|501,971|143,860|456,320|68,522|3,295,626|
|Net  Book Value|||||||
|At  31 March 2024|8,936,069|55,053|289,184|170,582|15,182|9,466,070|
|At  31 March 2023|9,138,163|97,535|32,448|215,706|22,834|9,506,686|





## 

## 

|FIXED<br>ASSET<br> <br>HOSPICE|INVES|T|ME|NTS|- GROU|P<br>AND||||
|---|---|---|---|---|---|---|---|---|---|
||||||||Investment|Listed|Total|
||||||||Properties|Investments|Investments|
|Market<br>value at 1 April<br>2023<br>Additions<br>at market value<br>Disposals<br>at cost<br>Revaluation|||||||940,000|3,553,356<br>596,900<br>(532,555)|4 493,356<br>5 96,900<br>(532,555)|
|Movement<br>in  investment|||cash|||||165,309<br>(9,362)|165,309<br>(9,362)|
|Group<br>Market<br> <br>March<br>2024|value||at|31|||940,000|3,773,648|4,713,648|
|Investment<br>in  subsidiaries||||||||||
|Share capital||||||||||
|.St Wilfrid's<br>Hospice<br>||(Eastbourne)|||Projects|Limited||||
|. St Wilfrid's<br>Hospice<br>||Eastbourne<br>|||Trading<br>|Company||||
|Limited||||||||||
|Hospice<br>Market<br> <br>March<br>2024|value||at|31|||||4,713,749|
|Historical<br>cost:||||||||||
|At  31 March<br>2024|||||||516,851|3,613,026|4,129,877|
|At  31 March<br>2023|||||||516,851|3,598,296|4,115,147|



|14.|DEBTORS|||Hospice|||Group|
|---|---|---|---|---|---|---|---|
||||2024||2023|2024|2023|
||||t||||t|
||Legacies<br>Trade debtors<br>Amounts<br>owed by  group undertakings||1 ,635,454<br>113,148<br>59,136||1,483,701<br>889,742<br>54,232|1,635,454<br>113,868|1,483,701<br>889,742|
||Prepayments<br> <br>Other debtors|& accrued income|334,328<br>36,514||471,531<br>87,579|357,829<br>36,514|471,531<br>87,579|
||||2,178,580||2,986,786|2,143,665|2,932,554|





## 

## 

|15.|CREDITORS:<br> <br>within<br>one year|amounts|falling|due|2024|Hospice|2023|2024|Group|2023|
|---|---|---|---|---|---|---|---|---|---|---|
||Trade creditors||||134,099||308,311|134,509||308,311|
||Taxes and  social <br>Other creditors|security|costs||151,614<br>64,257||109,360<br>87,280|151,614<br>64,309||109,360<br>97,511|
||Accruals||||98,124||53,745|121,119||56,160|
||Deferred<br>income||||158,851||990,945|158,851||990,945|
||||||606,945||1,549,641|630,402||1,562,287|



## 

## 



## 

## 

|RESTRICTED<br>INCOME|23/24|Balance<br>|at|Movement|in  funds|Balance<br>|at|
|---|---|---|---|---|---|---|---|
|||I April||||31 March||
|||2023||Income|Expenditure|2024||
||||||&  Transfers|||
||||||;E|||
|In Patient<br>Unit||1,213||48,967|(50,180)|||
|In  Patient<br>Unit Refurbishment<br>Cuddle<br>Bed Appeal<br>Hospice<br>In the  Community||||15,520<br>18 750<br>59 706|(59,868)|15,520<br>18,750<br>322||
|Therapies<br>& Living<br>Well  <br>Patient &  Family<br>Support|Service|||60,309|(266)<br>(60,309)|534||
|Care for the Carers<br>Other Restricted<br>Funds||||30,000<br>5,156|(30,000)<br>(5,156)|||
|Anne Beech Bursary<br>Fund<br>IPU Capital<br>& Improving<br> <br>Minibus<br>Appeal<br>BBC Children<br>in Need &<br>Spring<br>Appeal<br>2023<br>Syringe<br>Driver<br>Appeal|Patient Care Appeal<br>The  Seahorse Project|6,210<br>656<br>7,595<br>18,620<br>9,332||30,092<br>5,373<br>7,022|(656)<br>(355)<br>(26,645)<br>(16,021)<br>(16,354)|6,210<br>7,240<br>3,447<br>1972||
|Wellbeing<br>Appeal||4,343||||4,343||
|||49,253||280,895|(265,809)|64,338||





## 

|Prior<br>Year Restricted<br>Funds|Prior<br>Year Restricted<br>Funds|Balance<br>|at|Movement|in funds|Balance<br>at|
|---|---|---|---|---|---|---|
|||l April||||31 March|
|||2022||Income|Expenditure|2023|
||||||Transfers||
|[n  Patient<br>Unit<br>Hospice<br>In  the Community<br>Therapies<br>& Living<br>Well|Service|||4 630<br>44 677<br>5 800|(3,417)<br>(46,283)<br>(5,000)|1,213<br>484<br>800|
|Patient &  Family<br>Support||||80,538|(80,538)||
|Other Restricted<br>Funds||14,757||56,918|(71,675)||
|Anne Beech Bursaiy<br>Fund||||6,210||6,210|
|IPU Capital<br>&  Improving<br> <br>Minibus<br>Appeal|Patient Care Appeal|26,590<br>11,651|||(25,934)<br>(4,056)|656<br>7,595|
|Seahorse Project||6,389||28,358|(34,7 47)||
|Spirihial<br>Support<br>Appeal<br>Spring Appeal<br>2023<br>Syringe<br>Driver<br>Appeal<br>Wellbeing<br>Appeal||1,692<br>31,561||18,620<br>9,332|(1,692)<br>(27,218)|18,620<br>9,332<br>4,343|
|||94,730||255,083|(300,560)|49,253|





## 

## 

## 

||||Balanceat||Movementinfunds|Movementinfunds||Balanceat|
|---|---|---|---|---|---|---|---|---|
||||lApril|||||31March|
||||2023|Income|Expenditure|Gains/(losses)|Transfers|2024|
||||t|t|t|t|t|t|
|Asset Management<br>Reserve<br>Legacy Eqrialisation<br>Reserve<br>Strategic Development<br>Reserve<br>Fixed Asset Reserve<br>Property Revaluation<br>Reserve|||700,000<br>2,560,177<br>954,412<br>9,506,686<br>190,000||||(426,696)<br>(40,616)|700,000<br>2,133,481<br>954,412<br>9,466,070<br>190,000|
|Designated<br>funds|||13,911,275||||(467,312)|13,443,963|
|General<br>funds|||5,918,820|8,268,598|(10,396,177)|165,309|482,074|4,438,624|
|Total Unrestricted|Funds||19,830,095|8,268,598|(10,396,177)|165,309|14,762|17,882,587|
|Restricted<br>Funds|||49,253|280,895|(251,048)||(14,762)|64,338|
|Total Reserves|||19,879,348|8,549,493|(10,647,225)|165,309||17,946,925|
||||Balance at||Movement|in funds||Balance at|
||||I April|||||31 March|
||||2022|Income|Expenditure|Gains/(losses)|Transfers|2023|
|Asset Management<br>Reserve<br>Legacy Equalisation<br>Reserve<br>Strategic Development<br>Reserve<br>Fixed Asset Reserve<br>Revaluation<br>Reserve|||700.000<br>2.560.177<br>954.412<br>9.817.946<br>185.000||E|E<br>5,000|E<br>-<br>(311,260)<br>-|E<br>700,000<br>2,560,177<br>954,412<br>9,506,686<br>190,000|
|Designated<br>funds|||14,217,535|||5,000|(311,260)|13,911,275|
|General<br>funds|||5,465,065|9,435,537|(9,189,924)|(150,827)|358,968|5,918,820|
|Total Unrestricted<br>|Funds||19,682,600|9,435,537|(9,189,924)|(145,827)|47,708|19,830,095|
|Restricted<br>Funds|||94,730|255,083|(252,852)||(47,708)|49,253|
|Total Reserves|||19,771330|9,690,620|(9,442,776)|(145,827)||19,879,348|





## 

|20.|ANALYSIS<br>OF NET ASSETS<br>|ANALYSIS<br>OF NET ASSETS<br>|BETWEEN|BETWEEN||General|Designated|Restricted||
|---|---|---|---|---|---|---|---|---|---|
||FUNDS|||||Funds|Funds|Funds|Total|
|||||||||t||
||Fund balances<br>at 31 March|2024 are||represented|by:|||||
||Tangible<br>Fixed Assets<br>Fixed Asset Investments|||||4,713,648|9,466,070||9,466,070<br>4,713,648|
||Current<br>Assets|||||355,378|3,977,893|64,338|4,397,609|
||Creditors:<br>amounts<br>falling<br>|due  within||one  year||(630,402)|||(630,402)|
|||||||4,438,624|13,443,963|64,338|17,946,925|
||ANALYSIS<br>OF NET ASSETS||BETWEEN|||General|Designated|Restricted||
||FUNDS<br>-  Prior<br>Year|||||Funds|Funds|Funds|Total|
||Fund balances<br>at 31 March|2023 are||represented|by:|||||
||Tangible<br>Fixed ASsetS||||||9,506,686||9,506,686|
||Fixed Asset Investments|||||4,493,356|||4,493,356|
||Current<br>Assets|||||2,987,750|4,404,589|49,253|7,441,593|
||Creditors:<br>amounts<br>falling|due|within|one  year||(1,562,287)|||(1,562,287)|
|||||||5,918,819|13,911,275|49,253|19,879,348|





|21.|RECONCILIATION|||||OF NET|OF NET||INCOME<br>|INCOME<br>|TO|2024|2023|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||NET CASH<br>FLOW||||FROM<br>||OPERATmG||||ACTIVITIES|||
||Net income<br>for|the||reporting||||period<br>||(as per the||||
||statement<br>of financial|||||activities)||||||(1,932,423)|102,018|
||Adjustments<br>for:|||||||||||||
||Depreciation<br>charges|||||||||||391,791|429,359|
||Loss on  Disposal|of||Fixed ASSets|||||||||20,340|
||Losses/(Gains)<br>|on|investments|||||||||(165,309)|145,827|
||Dividends,<br>interest||and|||rent from|||investments|||(204,006)|(138,165)|
||(Profit)/loss<br>on|the|sale|||of fixed||assets||||(192)||
||Decrease/(increase)|||in||stocks||||||1,219|1,918|
||Decrease/(increase)|||in||debtors||||||788,889|2 59,098|
||Increase/(decrease)|||in|creditors|||||||(931,885)|(22,908)|
||Net cash provided|||by||operating|||activities|||(2,051,916)|797,487|
|22.|OPF,RATING<br>|IJ,ASES||||COMMn'MENTS||||||2024|2023|
||Group<br>Leases:|||||||||||||
||Within<br>one  year|||||||||||3,034|14,026|
||Within<br>two to five||years|||||||||38,765|40,629|
|||||||||||||'N,199|54,655|
||Charity<br>Leases:|||||||||||||
||Within<br>one  year|||||||||||3,034|14,026|
||Within<br>two to five||years|||||||||38,765|40,629|
|||||||||||||41,799|54,655|





## 

## 

|||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|
|||||Funds|Funds|2023|2022|
||||Notes|t|t||t|
|INCOME<br>FROM:||||||||
|Donations<br>and  Legacies|||2|5,399,070|255,083|5,654,253|4,673,778|
|Charitable<br>Activities||||||||
|Stahitory<br>Funding|||2|1,692,638||1,692,638|2,131,836|
|Non-Statutory<br>Funding|||2|536,744||536,744|534,813|
|Other trading<br>activities||||||||
|Income from Trading|||3|1,260,238||1,260,238|1 ,135,044|
|Income from Lottery||||352,349||352,349|362,300|
|Investments|||4|138,165||138,165|60,763|
|Other|||5|56,334||56,334|21,767|
|Total Income||||9,435,538|255,083|9,690,621|8,920,301|
|EXPENDITURE<br>ON:||||||||
|Raising<br>Funds||||||||
|Fundraising<br>Costs|||6|1,229,446|7,853|1,237,299|956,198|
|Trading Costs  of  Goods||Sold||||||
|and Other Costs|||3|1,154,486||1,154,486|968,999|
|Charitable<br>activities||||||||
|In Patient|||6|3,384,537|35,332|3,419,869|3,578,219|
|Therapies|||6|4 78,704|29,242|507,946|337,767|
|Community<br>Nursing|||6|2,561,750|58,901|2,620,651|2,107,777|
|Patient & Family Support|||6|isi,ooi|121,524|502,525|355,612|
|Total Expenditure||||9,189,924|252,852|9,442,776|8,304,572|
|Net  income/(expenditure)||||||||
|before net  gains/(losses)||on||245,614|2,231|247,845|615,729|
|investnnents||||||||
|Net  gains/(losses)<br>on|||13|(145,827)||(145,827)|253,288|
|investments||||||||
|Netincome/(expenditure)||||99,787|2,231|102,018|869,017|
|Gross  transfers between|funds||19|47,708|(47,708)|||
|Net  movement<br>in  funds||||147,495|(45,477)|102,018|869,017|
|Fund balances at 1 April|2022|||19,682,600|94,730|19,777,330|18,908,313|
|Fund balances at 31|March||20,21|19,830,095|49,253|19,879,348|19,777,330|
|2023||||||||